Invesco
KNSA icon

Invesco’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Invesco’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.4M Buy
772,806
+745,150
+2,694% +$38.7M ﹤0.01% 1117
2026
Q1 		$1.33M Sell
27,656
-4,678
-14% -$207K ﹤0.01% 2734
2025
Q4 		$1.33M Buy
32,334
+6,656
+26% +$267K ﹤0.01% 2785
2025
Q3 		$997K Buy
25,678
+5,389
+27% +$175K ﹤0.01% 2932
2025
Q2 		$561K Sell
20,289
-13,203
-39% -$336K ﹤0.01% 3106
2025
Q1 		$744K Buy
33,492
+19,384
+137% +$399K ﹤0.01% 2967
2024
Q4 		$279K Sell
14,108
-41,380
-75% -$944K ﹤0.01% 3433
2024
Q3 		$1.39M Buy
+55,488
New +$1.35M ﹤0.01% 2776
2024
Q2 		– Sell
-54,320
Closed -$1.07M – 3927
2024
Q1 		$1.07M Buy
54,320
+41,678
+330% +$814K ﹤0.01% 2958
2023
Q4 		$222K Sell
12,642
-199,954
-94% -$3.29M ﹤0.01% 3540
2023
Q3 		$3.69M Buy
+212,596
New +$3.58M ﹤0.01% 2356
2023
Q2 		– Sell
-13,109
Closed -$141K – 3900
2023
Q1 		$141K Sell
13,109
-200,449
-94% -$2.64M ﹤0.01% 3675
2022
Q4 		$3.2M Buy
213,558
+199,703
+1,441% +$2.91M ﹤0.01% 2452
2022
Q3 		$178K Buy
13,855
+1,622
+13% +$18.5K ﹤0.01% 3717
2022
Q2 		$118K Buy
12,233
+837
+7% +$7.81K ﹤0.01% 3859
2022
Q1 		$113K Buy
11,396
+156
+1% +$1.65K ﹤0.01% 3858
2021
Q4 		$133K Sell
11,240
-1,496
-12% -$18.4K ﹤0.01% 3860
2021
Q3 		$145K Buy
12,736
+1,751
+16% +$22.8K ﹤0.01% 3873
2021
Q2 		$153K Buy
+10,985
New +$167K ﹤0.01% 3835
2020
Q3 		– Sell
-50,074
Closed -$1.28M – 3662
2020
Q2 		$1.28M Buy
+50,074
New +$1.05M ﹤0.01% 2683
2019
Q1 		– Sell
-44,363
Closed -$1.25M – 3761
2018
Q4 		$1.25M Buy
+44,363
New +$926K ﹤0.01% 2845

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Invesco's KNSA Position: Q2 2026 in Review

Invesco increased its Kiniksa Pharmaceuticals (KNSA) stake by 2,694% in Q2 2026, buying an estimated $38.7M and bringing the position to 772,806 shares worth $49.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

Invesco first reported a position in KNSA in Q4 2018 and has held it in 21 quarters since. 267 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Invesco held 772,806 shares of Kiniksa Pharmaceuticals worth $49.4M as of Q2 2026.
  • Invesco bought 745,150 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $38.7M.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #1117 holding.
  • Invesco first reported a position in Kiniksa Pharmaceuticals in Q4 2018 and has held it in 21 quarters since.
  • 267 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.